Investing Profile

Patrick Heron

InvestorVC
Managing Partner at Frazier Healthcare Partners
frazierhealthcare.com/team/pa...Menlo Park, California
Photo of Patrick Heron, Managing Partner at Frazier Healthcare Partners
cb
$100K - $5.0M
$1.5M
19
CompanyStageDateRound SizeTotal Raised
Alpha9 Theranostics
Series COct 2024$180M
Series BDec 2022$75M
$250M
Co-investors: Melissa McCracken (Nextech Invest), Cory Freedland (Samsara BioCapital)
MBX Biosciences
Series BNov 2022$120M
Series AJul 2020$35M
$150M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Carl Gordon (OrbiMed)
SanReno Therapeutics
UndisclosedNov 2021$40M
$40M
HilleVax
Series UnknownSep 2021$140M
$140M
Passage Bio
Series BSep 2019$110M
Series AFeb 2019$120M
$230M
Co-investors: Carl Gordon (OrbiMed), Liam Ratcliffe (Access Biotechnology)
Recida Therapeutics
Series AFeb 2019$9M
$9M
Mirum Pharmaceuticals
Series ANov 2018$120M
$120M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Niall O’Donnell (RiverVest), Jonathan Leff (Deerfield Management)
Zavante Therapeutics
Series AMar 2016$45M
$45M
Co-investors: Andrew Schiff (Aisling Capital)